somatostatin-28-(1-12) and Hepatic-Encephalopathy

somatostatin-28-(1-12) has been researched along with Hepatic-Encephalopathy* in 1 studies

Other Studies

1 other study(ies) available for somatostatin-28-(1-12) and Hepatic-Encephalopathy

ArticleYear
Reduced somatostatin-like immunoreactivity in the brain of LEC rats with hepatic encephalopathy.
    Regulatory peptides, 1991, Oct-01, Volume: 36, Issue:1

    Somatostatin-14-like immunoreactivity (S14LI) and somatostatin-28(1-12)-like immunoreactivity (S28(1-12)LI) in the brain of LEC (Long Evans Cinnamon) rats with hepatic encephalopathy were measured. Significant reduction of both S14LI and S28(1-12)LI was observed in the hypothalamus, medulla oblongata, striatum and spinal cord. Both of the immunoreactivities in the hypothalamus of these rats were approx. 50% of those in LEC rats without hepatic encephalopathy. The amounts of reduction of S14LI significantly correlated with those of reduction of S28(1-12)LI. No significant difference in gel chromatographic profiles of S14LI and S28(1-12)LI was observed between LEC rats with and without hepatic encephalopathy. These results suggest that the reduction of somatostatin-like immunoreactivity in LEC rats with hepatic encephalopathy may be caused by a decrease in production of prosomatostatin rather than altered degradation.

    Topics: Animals; Blood Chemical Analysis; Central Nervous System; Corpus Striatum; Disease Models, Animal; Hepatic Encephalopathy; Hypothalamus; Medulla Oblongata; Peptide Fragments; Rats; Rats, Inbred Strains; Somatostatin; Somatostatin-28; Spinal Cord

1991